Phase 1 results of Oncobax-AK in combination with ipilimumab/nivolumab in advanced clear cell renal cell carcinoma (ccRCC; NCT05865730). This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
An experimental cultivation, transcriptomic, and overexpression study found that low temperature was required for primordium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results